Since the PLN-R14del pathogenic variant is the root cause of this heart disease, elimination of PLN expression can be considered a very promising therapeutic approach, providing a great example of a potential personalized medicine for PLN-R14del carriers. The gene discussed is PLN; the disease is heart disorder.